Today: 9 June 2026
Browse Category

NYSE:TMO 31 July 2025 - 4 December 2025

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific shares traded near $580 midday Tuesday, down less than 1% but close to their 52-week high of $611. HSBC raised its price target on the stock to $670. The company recently announced a €2.1 billion bond sale and a $5 billion share repurchase plan. An insider filed to sell 6,912 shares valued at about $4 million.
2 December 2025
··
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific shares traded at $584–585 on December 1, 2025, with a market cap near $223 billion and a P/E ratio of 34.2. HSBC upgraded the stock to “Buy” the same day, citing improved prospects. Boston Family Office increased its stake by 3% in Q2, while First National Advisers cut its position by 59%. Institutional investors hold about 89% of the float.
1 December 2025
··
Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific traded near $590.83 per share late Friday, with a market cap of about $222 billion. Institutional investors, including Global Retirement Partners and Laurel Wealth Advisors, disclosed new or increased stakes. An executive vice president sold $6.43 million in shares. The stock remains near its 52-week high of just over $610.
29 November 2025
·
Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher (TMO) closed at $558.07 on Oct 21, up 2.6% for the day and over 11% in October, rebounding from a 10% year-over-year dip. The company has spent $2 billion on U.S. operations and announced a $4.1 billion deal for Solventum’s filtration business. Q3 results are due Oct 22, with analysts expecting EPS of ~$5.50 and revenue near $10.91 billion. JP Morgan raised its 12-month price target to $650.
21 October 2025
·
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····
Beyond the Eyepiece: The Next-Gen Microscopes of 2025–2026 Revolutionizing How We See the World

Beyond the Eyepiece: The Next-Gen Microscopes of 2025–2026 Revolutionizing How We See the World

Zeiss launched Lightfield 4D in March 2025, enabling instant volumetric imaging in LSM 910/990 microscopes at up to 80 stacks per second, with Microscopy Copilot AI. Nikon released the Eclipse Ti2-I in July 2025 for IVF clinics, consolidating controls and reducing workflow steps by up to 75%. Leica’s Visoria series debuted in May 2025 with tablet-based viewing and automatic metadata encoding.
31 July 2025
····
1 2 3 4

Stock Market Today

  • Aecon Group TSX Dividend Stock Drops 20% – A Buy for Long-Term Investors
    June 8, 2026, 9:40 PM EDT. Aecon Group (TSX:ARE), a $3.1 billion market cap infrastructure firm, has dropped 20% from its 52-week high, presenting a rare buying opportunity. The company has shifted focus from cyclical civil construction to power projects, including nuclear and utilities, sectors with sustained demand. Aecon completed the Darlington Nuclear Refurbishment under budget and ahead of schedule, highlighting its strong execution. In 2025, revenue hit a record $5.4 billion, with a backlog reaching $10.9 billion in Q1 2026. The company improved margins by moving to collaborative contract models and strengthened its balance sheet by reducing debt. Aecon offers a 1.6% dividend yield with consistent growth, supported by projected free cash flow increases from $35 million in 2025 to $155 million in 2027.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Go toTop